Conrad Wai, the CEO of $CLOV, sold 118,600 shares of the company on 07-22-2025 for an estimated $390,194. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.4% of their shares of this class of stock. Following this trade, they now own 1,494,898 shares of this class of $CLOV stock.
$CLOV Insider Trading Activity
$CLOV insiders have traded $CLOV stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- CARLADENISE ARMBRISTER EDWARDS sold 200,000 shares for an estimated $722,000
- CONRAD WAI (CEO, Counterpart Health) has made 0 purchases and 2 sales selling 209,797 shares for an estimated $692,968.
- BRADY PATRICK PRIEST (CEO of Home Care) sold 75,000 shares for an estimated $276,000
- KAREN SOARES (General Counsel & Secretary) sold 52,500 shares for an estimated $199,500
- JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 3 sales selling 42,251 shares for an estimated $115,276.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLOV Hedge Fund Activity
We have seen 97 institutional investors add shares of $CLOV stock to their portfolio, and 87 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 4,558,305 shares (+365.9%) to their portfolio in Q1 2025, for an estimated $16,364,314
- VANGUARD GROUP INC added 994,904 shares (+5.1%) to their portfolio in Q1 2025, for an estimated $3,571,705
- BANK OF AMERICA CORP /DE/ added 979,733 shares (+344.7%) to their portfolio in Q1 2025, for an estimated $3,517,241
- CITADEL ADVISORS LLC added 822,712 shares (+90.3%) to their portfolio in Q1 2025, for an estimated $2,953,536
- 8 KNOTS MANAGEMENT, LLC added 817,905 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,936,278
- MARSHALL WACE, LLP added 805,762 shares (+21.4%) to their portfolio in Q1 2025, for an estimated $2,892,685
- JANE STREET GROUP, LLC added 796,014 shares (+149.6%) to their portfolio in Q1 2025, for an estimated $2,857,690
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLOV Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 03/03/2025
To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
